Medigene AG

FSX:MDG1.DE

1.618 (EUR) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 6.03431.24710.4638.74910.6327.75411.3759.7496.80813.7847.5926.2844.6562.29239.46639.60623.87731.224
Cost of Revenue 3.0531.9831.361.2920.3830.8491.6211.4021.1032.0861.7351.250.9530.78131.48226.926-18.493-10.669
Gross Profit 2.98129.2649.1037.45710.2496.9059.7548.3475.70511.6985.8575.0343.7031.5117.98412.6842.3741.893
Gross Profit Ratio 0.4940.9370.870.8520.9640.8910.8570.8560.8380.8490.7710.8010.7950.6590.2020.321.7751.342
Reseach & Development Expenses 10.71628.49912.79722.26222.6227.21314.87711.5388.5297.4986.6057.39911.25413.49418.49927.465-16.942-12.337
General & Administrative Expenses 4.2914.9932.8243.6152.7262.7522.5822.4692.2672.2932.5362.7875.8317.3696.932-7.72100
Selling & Marketing Expenses 0.0050.080.1160.6530.260.4341.2592.6240.8990.7620.8060.8592.2722.032.1922.763-0.916-0.753
SG&A 8.7555.0732.944.2682.9863.1863.8415.0933.1663.0553.3423.6468.1039.3999.124-4.958-0.916-0.753
Other Expenses 4.6994.4193.3514.264.80214.1531.9322.4394.4494.0264.191-6.16606.212-2.42-66.29600
Operating Expenses 19.47137.99119.08830.7930.4124.7323.14321.56316.14414.57914.13815.30819.35729.10527.623-19.02-17.858-13.09
Operating Income -16.49-8.715-9.985-23.333-20.161-17.825-13.389-13.216-10.439-2.881-9.021-16.44-15.654-27.594-19.63931.7-31.667-8.359
Operating Income Ratio -2.733-0.279-0.954-2.667-1.896-2.299-1.177-1.356-1.533-0.209-1.188-2.616-3.362-12.039-0.4980.8-1.326-0.268
Total Other Income Expenses Net -0.102-0.659-0.298-5.070.2430.8211.535.861-2.96-3.031-1.983-4.5210.180.417-2.296-64.84600
Income Before Tax -16.592-9.374-10.283-28.403-19.918-17.004-12.939-9.72-13.399-5.912-10.264-14.795-15.474-27.177-21.935-33.14600
Income Before Tax Ratio -2.75-0.3-0.983-3.246-1.873-2.193-1.137-0.997-1.968-0.429-1.352-2.354-3.323-11.857-0.556-0.83700
Income Tax Expense -0.415-1.044-0.30.4720.0440.0450.634-0.228-0.4-0.1550.0180.082-1.241-8.890.027-2.35666.22730.65
Net Income -16.177-8.33-9.983-28.875-19.962-17.049-13.573-9.492-12.999-5.757-10.282-9.8596.281-17.869-21.962-30.79-29.876-6.891
Net Income Ratio -2.681-0.267-0.954-3.3-1.878-2.199-1.193-0.974-1.909-0.418-1.354-1.5691.349-7.796-0.556-0.777-1.251-0.221
EPS -0.66-0.34-0.41-1.18-0.81-0.72-0.63-0.48-0.77-0.47-1.07-1.060.68-1.95-2.57-3.62-3.79-0.96
EPS Diluted -0.66-0.34-0.41-1.18-0.81-0.72-0.63-0.48-0.77-0.47-1.07-1.060.68-1.95-2.57-3.62-3.79-0.96
EBITDA -15.02713.137-6.491-21.503-17.096-15.286-10.538-11.803-9.479-3.301-7.196-14.908-10.082-17.115-21.099-26.02837.7124.827
EBITDA Ratio -2.490.42-0.62-2.458-1.608-1.971-0.926-1.211-1.392-0.239-0.948-2.372-2.165-7.467-0.535-0.6571.5790.795